278 related articles for article (PubMed ID: 8881271)
1. [Gene therapy for hereditary immunodeficiencies].
Fischer A; de Saint-Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
C R Seances Soc Biol Fil; 1996; 190(1):77-93. PubMed ID: 8881271
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy of primary immunodeficiencies.
Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
[No Abstract] [Full Text] [Related]
3. Gene therapy for inherited immunodeficiencies.
Howe S; Thrasher AJ
Curr Hematol Rep; 2003 Jul; 2(4):328-34. PubMed ID: 12901330
[TBL] [Abstract][Full Text] [Related]
4. Primary immunodeficiencies: molecular aspects and treatment.
Fischer A
Bone Marrow Transplant; 1992; 9 Suppl 1():39-43. PubMed ID: 1354525
[No Abstract] [Full Text] [Related]
5. Gene therapy for primary adaptive immune deficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy of severe combined immunodeficiencies.
Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Cavazzana-Calvo M
Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
[TBL] [Abstract][Full Text] [Related]
8. Progress and prospects: gene therapy for inherited immunodeficiencies.
Qasim W; Gaspar HB; Thrasher AJ
Gene Ther; 2009 Nov; 16(11):1285-91. PubMed ID: 19776764
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
Hershfield MS
Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
[TBL] [Abstract][Full Text] [Related]
10. Severe combined immunodeficiencies.
Fischer A
Immunodefic Rev; 1992; 3(2):83-100. PubMed ID: 1554500
[TBL] [Abstract][Full Text] [Related]
11. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
12. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
13. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
14. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for primary immunodeficiencies.
Thrasher AJ
Immunol Allergy Clin North Am; 2008 May; 28(2):457-71, xi. PubMed ID: 18424342
[TBL] [Abstract][Full Text] [Related]
16. Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
Fischer A; Le Deist F; Hacein-Bey-Abina S; André-Schmutz I; Basile Gde S; de Villartay JP; Cavazzana-Calvo M
Immunol Rev; 2005 Feb; 203():98-109. PubMed ID: 15661024
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for hematopoietic and immune disorders.
Kohn DB
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S55-8. PubMed ID: 8971410
[TBL] [Abstract][Full Text] [Related]
18. In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy: role of CD8+ cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient.
Kawamura N; Ariga T; Ohtsu M; Kobayashi I; Yamada M; Tame A; Furuta H; Okano M; Egashira M; Niikawa N; Kobayashi K; Sakiyama Y
J Immunol; 1999 Aug; 163(4):2256-61. PubMed ID: 10438969
[TBL] [Abstract][Full Text] [Related]
19. Update on gene therapy of inherited immune deficiencies.
Engel BC; Kohn DB; Podsakoff GM
Curr Opin Mol Ther; 2003 Oct; 5(5):503-7. PubMed ID: 14601519
[TBL] [Abstract][Full Text] [Related]
20. Molecular defects in T- and B-cell primary immunodeficiency diseases.
Cunningham-Rundles C; Ponda PP
Nat Rev Immunol; 2005 Nov; 5(11):880-92. PubMed ID: 16261175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]